| Term 
 
        | Action of Penicillin bind to PBPs, inactivates: 
transpeptidase for cell wall synthesis 
inhibitors of autolytic enzymes so cell lysis and die |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Methicillin is highly resistant to beta-lactamase   if the bug is meticillin resistant, then another cause the resistance. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fight Resistance 1, Clavulanic Acid  bind to Beta lactamase and inactivate it. 2,Beta-lactam Analogs  (not recognized by B-lactamase) eg: Cephalosporin, monobactam, carbapenem |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cephalosporins: Resistant to B-lactamase. 3 generations   1st generation like penicillin mostly for gram +   3rd generation works mostly for gram -, highly penetrant into CSF, good for meningitis. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cephalosporins Resistance   inability to reach site of action due to mutation   Alteration in PBPs |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vancomycin, last resort agent large ampiphilic molecule. cell wall inhibitor like penicillin, but diff mechanism B-lactamase resistant due to lack of B-lactam ring,   works by binding covalently to glycopeptide polymer to disrupt cell wall.  |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vancomycin Resistance   conversion from D-alanine to D-lactate by evolution   thus vancomycin can't |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Absorption of Vancomycin poor absorption after oral. IV Antimicrobial activity of Vancomycin: against gram + synergism with aminoglycoside against S. aureus and Enterococcus   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Metabolic Inhibitors in Synergistic Combination   1, Sulfonamides block first step, inhibit production of DHFA from PABA, it's bac-specific coz we don't use PABA to make DHFA, we eat folic acid instead. 
     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2, Trimethoprim    inhibits DHFR enzyme which reduce DHFR to make Tetrahydrofolic acid (critical for thymidine production) 
   Trimethoprim has high affinity to bacterial DHFR 
   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfonamide   rarely used as single agent treat UTI as single agent topical ophthalmic ointment or solution topical ointment for burn |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse RXN of Sulfonamides   cross-allergenic with thiazide precipitate in urin hemolytic/aplastic anemia hemolytic rxn in G6PD deficient patient |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Resistance to Trimethoprim   reduced permeability   amplification of DHFR, bac makes more DHFR enzyme   mutations reducing DHFR binding   
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Co-trimoxazole (combination of trimethoprin and sulfamethoxazole)     Reduced toxicity & resistance
 lower dose to reach MIC when combined |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-fungal Targets cell walls cell membrane enzyme in cell membrane produce ergosterol that is fungal specific.   nucleic acid synthesis   
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amphotericin target yeast specific membrane steroid ergostrol   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics of Amphotericin poor absorption from GI 90% bound by serum proteins Slow excretion in urine lipophilic nature, widely ditributed in tissues 2-3% in CNS, not good for meningitis     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Resistance to Amphotericin occurs when..   1, reduced ergosterol or 2, modified ergosterol, reduced affinity |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse Effect of Amphotericin   Immediate toxicity: fever, chills, muscle spasm, vom, H/A, HTN   Slower toxicity: renal damage, abnormality of liver fxn CNS effect such as seizures   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clinical use of Amphotericin 
 induction therapy follow by Azole as maintenance life threatening mycotic infection topical administration due to poor absorption |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Azole broad spectrum antifungal agents   eg: Fluconazole: high oral bioavailability Prophylaxix in AID & immunocompromised ppl  good for cryptococcal meningitis |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Flucytosine   inhibits thymidylate synthetase   methylation of dUMP to dTMP for thymidine   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Flucytosine  pro-drug : cytosine deaminase (fungal specific)  convert flucytosine to 5-FU (anti-cancer drug) ↓ 5-FU → 5-FUMP→5-FdUMP 5-FdUMP is the active drug that inhibit thymidylate synthetase. Works like trimethoprim for antibac.   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Resistanct to Flucytosine   altered metabolism of flucytosine   occur when used alone. 
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse Effect   bacteria in GI die, toxic to human cell bone marrow toxicity derangement of liver fxn narrow therapeutic window |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clinical Use of Flucytosine   not used as single agent due to fast resistance   in combination with amphotericin B or itraconazole. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Azoles inhibit sterol 14-a-demethylase which is an enzyme that makes ergosterol broad spectrum prophylaxis in AIDS and transplant pt   Clotrimazole: for superficial fungal infection   Nystatin: more toxic, topical use only |  | Definition 
 | 
        |  |